drug-related side effects and adverse reactions

Explore academic connections and research related to this keyword

207
Views
5
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial
Vitolo U;Chiappella A;Ferreri AJ;Martelli M;Baldi I;Balzarotti M;Bottelli C;Conconi A;Gomez H;Lopez-...
2011 journal of clinical oncology : official journal of... 419 views
2
American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines
;
1994 journal of clinical oncology : official journal of... 302 views
3
Predictors of aspiration pneumonia: how important is dysphagia?
Langmore SE;Terpenning MS;Schork A;Chen Y;Murray JT;Lopatin D;Loesche WJ;;
1970 dysphagia 328 views
4
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review
Jenkins A;Thomson AH;Brown NM;Semple Y;Sluman C;MacGowan A;Lovering AM;Wiffen PJ; ;;
2016 The Journal of antimicrobial chemotherapy 224 views
5
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review
Jenkins, Abi;(BSAC Working Party on Therapeutic Drug Monitoring);Thomson, Alison H.;(BSAC Working Pa...
2016 journal of antimicrobial chemotherapy 189 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult male aged middle aged Recurrence Prospective Studies Clinical Trial Antibodies Monoclonal Multicenter Study